BREZTRI AEROSPHERE

astrazeneca canada inc🇨🇦 Health Canada

Approval Id: e0568959814fe207
Drug Approval Canada Name: BREZTRI AEROSPHERE
Product Name: BREZTRI AEROSPHERE
Status: Marketed
Status Date: 2024-01-05
Original Market Date: 2021-12-03
Din: 02518058
Drug Class: Human
Dosage Form: Aerosol, Metered Dose
Route Of Administration: Inhalation
Schedule: Prescription
Ahfs: 12:08.08
Atc Original: R03AL11 FORMOTEROL, GLYCOPYRRONIUM BROMIDE AND BUDESONIDE
Atc Name: r 03 al 11
Aig Number: 0363070002
Company Name: astrazeneca canada inc
Company Address: 1004 Middlegate Road, Suite 5000, Mississauga, Ontario, Canada, L4Y 1M4

BUDESONIDE

160 MCG / ACT

FORMOTEROL FUMARATE DIHYDRATE

5 MCG / ACT

GLYCOPYRRONIUM (GLYCOPYRROLATE)

7.2 MCG / ACT

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

e0568959814fe207

Type

Standard